Stockreport

Cystatin C Assay Market Poised to Reach Over US$ 1.2 Billion by 2034, Driven by Advances in Renal Diagnostics | Transparency Market Research [Yahoo! Finance]

SIEMENS AG SPONS ADR  (SIEGY) 
NASDAQ:AMEX Investor Relations: siemens.com/investor
PDF With chronic kidney disease (CKD) becoming a critical global health issue, the market is projected to grow at a robust CAGR of 6.6% from 2024 to 2034, doubling its value [Read more]